These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2606689)

  • 1. Aerosol deposition in the nose as a function of body size.
    Phalen RF; Oldham MJ; Mautz WJ
    Health Phys; 1989; 57 Suppl 1():299-305. PubMed ID: 2606689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal Filtration of Inhaled Aerosol in Human Subjects as a Function of Nasal Pressure Drop.
    Golshahi L; Hosseini S
    J Aerosol Med Pulm Drug Deliv; 2019 Feb; 32(1):13-23. PubMed ID: 30199315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth of nasal and laryngeal airways in children: implications in breathing and inhaled aerosol dynamics.
    Xi J; Si X; Zhou Y; Kim J; Berlinski A
    Respir Care; 2014 Feb; 59(2):263-73. PubMed ID: 23821760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal deposition in infants and children.
    Zhou Y; Guo M; Xi J; Irshad H; Cheng YS
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):110-6. PubMed ID: 23586501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of electrostatic charge on deposition of uniformly charged monodisperse particles in the nasal extrathoracic airways of an infant.
    Azhdarzadeh M; Olfert JS; Vehring R; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):30-4. PubMed ID: 24689985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First Steps to Develop and Validate a CFPD Model in Order to Support the Design of Nose-to-Brain Delivered Biopharmaceuticals.
    Engelhardt L; Röhm M; Mavoungou C; Schindowski K; Schafmeister A; Simon U
    Pharm Res; 2016 Jun; 33(6):1337-50. PubMed ID: 26887679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental measurements and computational predictions of regional particle deposition in a sectional nasal model.
    Schroeter JD; Tewksbury EW; Wong BA; Kimbell JS
    J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):20-9. PubMed ID: 24580111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Models of Inhalation Therapy in Early Childhood: Therapeutic Aerosols in the Developing Acinus.
    Katan JT; Hofemeier P; Sznitman J
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):288-98. PubMed ID: 26907858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Sophia Anatomical Infant Nose-Throat (Saint) model: a valuable tool to study aerosol deposition in infants.
    Janssens HM; de Jongste JC; Fokkens WJ; Robben SG; Wouters K; Tiddens HA
    J Aerosol Med; 2001; 14(4):433-41. PubMed ID: 11791684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breathing resistance and ultrafine particle deposition in nasal-laryngeal airways of a newborn, an infant, a child, and an adult.
    Xi J; Berlinski A; Zhou Y; Greenberg B; Ou X
    Ann Biomed Eng; 2012 Dec; 40(12):2579-95. PubMed ID: 22660850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Particle deposition efficiency of therapeutic aerosols in the human maxillary sinus.
    Hyo N; Takano H; Hyo Y
    Rhinology; 1989 Mar; 27(1):17-26. PubMed ID: 2740721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deposition of monodisperse particles in hollow models representing adult and child-size tracheobronchial airways.
    Oldham MJ; Mannix RC; Phalen RF
    Health Phys; 1997 Jun; 72(6):827-34. PubMed ID: 9169924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric in vitro and in silico models of deposition via oral and nasal inhalation.
    Carrigy NB; Ruzycki CA; Golshahi L; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):149-69. PubMed ID: 24870701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of particle deposition in the turbinate and olfactory regions using a human nasal computational fluid dynamics model.
    Schroeter JD; Kimbell JS; Asgharian B
    J Aerosol Med; 2006; 19(3):301-13. PubMed ID: 17034306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the regional deposition in a model nose of a drug discharged from metered aerosol and metered-pump nasal delivery systems.
    Hallworth GW; Padfield JM
    J Allergy Clin Immunol; 1986 Feb; 77(2):348-53. PubMed ID: 3944385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particle deposition and resistance in the noses of adults and children.
    Becquemin MH; Swift DL; Bouchikhi A; Roy M; Teillac A
    Eur Respir J; 1991 Jun; 4(6):694-702. PubMed ID: 1889496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfactory deposition of inhaled nanoparticles in humans.
    Garcia GJ; Schroeter JD; Kimbell JS
    Inhal Toxicol; 2015; 27(8):394-403. PubMed ID: 26194036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Powder aerosol delivery through nasal high-flow system: In vitro feasibility and influence of process conditions.
    Okuda T; Tang P; Yu J; Finlay WH; Chan HK
    Int J Pharm; 2017 Nov; 533(1):187-197. PubMed ID: 28830783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-nasal distribution of aerosols with or without vibration.
    Sato Y; Hyo N; Sato M; Takano H; Okuda S
    Z Erkr Atmungsorgane; 1981; 157(3):276-80. PubMed ID: 7340212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon nanotubes size classification, characterization and nasal airway deposition.
    Su WC; Cheng YS
    Inhal Toxicol; 2014 Dec; 26(14):843-52. PubMed ID: 25289729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.